Description
A COX-2 inhibitor (IC50 = 6.6 nM); selective over COX-1 (IC50 = 210 nM); inhibits PGE2 production in a rabbit model of LPS-induced eye inflammation; decreases inflammation following cataract removal in dogs (0.9% topically on a tapering schedule for 24 weeks)
Formal name: 2-amino-3-(4-bromobenzoyl)-benzeneacetic acid, monosodium salt
Synonyms: AHR 10282B
Molecular weight: 356.2
CAS: 91714-93-1
Purity: ≥99%
Formulation: A powder
Application||Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Ophthalmology